Next Article in Journal
Microfluidic-Based Amplification-Free Bacterial DNA Detection by Dielectrophoretic Concentration and Fluorescent Resonance Energy Transfer Assisted in Situ Hybridization (FRET-ISH)
Next Article in Special Issue
Evaluation of Impedance-Based Label-Free Technology as a Tool for Pharmacology and Toxicology Investigations
Previous Article in Journal
Water-Soluble Electrospun Nanofibers as a Method for On-Chip Reagent Storage
Biosensors 2012, 2(4), 396-404; doi:10.3390/bios2040396
Review

The Use of Angiotensin-I Converting Enzyme I/D Genetic Polymorphism as a Biomarker of Athletic Performance in Humans

1,2,*  and 2
Received: 17 August 2012; in revised form: 17 September 2012 / Accepted: 24 September 2012 / Published: 9 October 2012
(This article belongs to the Special Issue Multiplex and Multiparametric Sensing Devices)
View Full-Text   |   Download PDF [137 KB, uploaded 9 October 2012]
Abstract: Angiotensin II is a key regulator of blood pressure and cardiovascular function in mammals. The conversion of angiotensin into its active form is carried out by Angiotensin I-Converting Enzyme (ACE). The measurement of ACE concentration in plasma or serum, its enzymatic activity, and the correlation between an insertion/deletion (I/D) genetic polymorphism of the ACE gene have been investigated as possible indicators of superior athletic performance in humans. In this context, other indicators of superior adaptation to exercise resulting in better athletic performance (such as ventricular hypertrophy, VO2 max, and competition results) were mostly used to study the association between ACE I/D polymorphism and improved performance. Despite the fact that the existing literature presents little consensus, there is sufficient scientific evidence to warrant further investigation on the usage of ACE activity and the I/D ACE gene polymorphism as biomarkers of superior athletic performance in humans of specific ethnicities or in athletes involved in certain sports. In this sense, a biomarker would be a substance or genetic component that could be measured to provide a degree of certainty, or an indication, of the presence of a certain trait or characteristic that would be beneficial to the athlete’s performance. Difficulties in interpreting and comparing the results of scientific research on the topic arise from dissimilar protocols and variation in study design. This review aims to investigate the current literature on the use of ACE I/D polymorphism as a biomarker of performance in humans through the comparison of scientific publications.
Keywords: Angiotensin I Converting Enzyme; athletic performance; biomarker Angiotensin I Converting Enzyme; athletic performance; biomarker
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

De Mello Costa, M.F.; Slocombe, R. The Use of Angiotensin-I Converting Enzyme I/D Genetic Polymorphism as a Biomarker of Athletic Performance in Humans. Biosensors 2012, 2, 396-404.

AMA Style

De Mello Costa MF, Slocombe R. The Use of Angiotensin-I Converting Enzyme I/D Genetic Polymorphism as a Biomarker of Athletic Performance in Humans. Biosensors. 2012; 2(4):396-404.

Chicago/Turabian Style

De Mello Costa, Maria Fernanda; Slocombe, Ron. 2012. "The Use of Angiotensin-I Converting Enzyme I/D Genetic Polymorphism as a Biomarker of Athletic Performance in Humans." Biosensors 2, no. 4: 396-404.


Biosensors EISSN 2079-6374 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert